Dude
Senior Member
- Messages
- 209
Descrption:
Efgartigimod may be a viable treatment option for individuals diagnosed with post-COVID-19 POTS because it has been shown to reduce IgG levels, including IgG autoantibodies, which may underlie some of the autonomic disease manifestations in these patients.
https://classic.clinicaltrials.gov/ct2/show/NCT05633407
It's been going on for a while, has anyone heard anything about it? Studies should be completed in December 2023. Maybe they were clever and let the patients sign an nda, which is not the case everywhere
Efgartigimod may be a viable treatment option for individuals diagnosed with post-COVID-19 POTS because it has been shown to reduce IgG levels, including IgG autoantibodies, which may underlie some of the autonomic disease manifestations in these patients.
https://classic.clinicaltrials.gov/ct2/show/NCT05633407
It's been going on for a while, has anyone heard anything about it? Studies should be completed in December 2023. Maybe they were clever and let the patients sign an nda, which is not the case everywhere